To measure the frequency of persistent liver dysfunction (raised liver enzymes, serum albumin, prothrombin time, etc) in recovered COVID -19 patients. To compare the hepatic manifestations in post COVID -19 patients with and without liver disease
The digestive tract, particularly the liver, has recently been reported to be affected by
SARS-CoV-2. Although abnormal liver enzymes were regularly described as an extra-pulmonary
clinical feature, and almost one half of patients experienced grades of hepatic injury. liver
damage in patients with SARS infections was primarily manifested in the mild and moderate
elevation of alanine and/or aspartate aminotransferases (ALT and AST) with some degree of
hypoalbuminemia and hyperbilirubinemia during the early stage of the illness.
Diagnostic Test: liver function , prothrombin time , INR , US .
analytic
Inclusion Criteria:
- Patients previously diagnosed by COVID 19 eg : PCR and / or HRCT chest, lab of more
than 1 month duration.
Exclusion Criteria:
- Patients less than 18 y.
- Patients with acute COVID 19.
Faculty of Medicine
Assiut, Egypt
Khaled Abu Bakr, Study Director
Assiut University